Captor Therapeutics ®
News
February 22, 2022
Captor Therapeutics opens State-of-the-Art Proteomics Lab
February 02, 2022
Captor Therapeutics strengthens its scientific team and prepares for the launch of clinical trials in 2023 with the appointment of Dr. Robert Dyjas as Director of Medical Affairs and Clinical Development
January 13, 2022
Captor Therapeutics Presents Compelling In Vivo Proof-of-Concept Data from CT-01 Program in Hepatocellular Carcinoma
December 15, 2021
Captor Therapeutics to attend the 11th Annual LifeSci Partners Corporate Access Event
December 01, 2021
Captor Therapeutics Presents 3Q’21 Financial Results and Provides a Business Update
November 08, 2021
Captor Therapeutics is one of the founders of the BioInMed - Polish Association of Innovative Medical Biotechnology Companies
October 26, 2021
Captor Therapeutics to Present at the 4th Annual Targeted Protein Degradation Summit
October 15, 2021
Captor Therapeutics presents H1 2021 financial results and provides business update